BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 25894639)

  • 1. Progressive osseous heteroplasia, as an isolated entity or overlapping with Albright hereditary osteodystrophy.
    Lin MH; Numbenjapon N; Germain-Lee EL; Pitukcheewanont P
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):911-8. PubMed ID: 25894639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive osseous heteroplasia-like heterotopic ossification in a male infant with pseudohypoparathyroidism type Ia: a case report.
    Gelfand IM; Hub RS; Shore EM; Kaplan FS; Dimeglio LA
    Bone; 2007 May; 40(5):1425-8. PubMed ID: 17321228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the variety of GNAS inactivation disorders and their clinical manifestations in 11 Chinese children.
    Chang G; Li Q; Li N; Li G; Li J; Ding Y; Huang X; Shen Y; Wang J; Wang X
    BMC Endocr Disord; 2022 Mar; 22(1):70. PubMed ID: 35296306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for GNAS genetic and epigenetic alterations in progressive osseous heteroplasia: first Italian series.
    Elli FM; Barbieri AM; Bordogna P; Ferrari P; Bufo R; Ferrante E; Giardino E; Beck-Peccoz P; Spada A; Mantovani G
    Bone; 2013 Oct; 56(2):276-80. PubMed ID: 23796510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification.
    Adegbite NS; Xu M; Kaplan FS; Shore EM; Pignolo RJ
    Am J Med Genet A; 2008 Jul; 146A(14):1788-96. PubMed ID: 18553568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endochondral ossification in a case of progressive osseous heteroplasia in a young female child.
    Schrander DE; Welting TJ; Caron MM; Schrander JJ; van Rhijn LW; Körver-Keularts I; Schrander-Stumpel CT
    J Pediatr Orthop B; 2014 Sep; 23(5):477-84. PubMed ID: 24626099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive osseous heteroplasia is not a Mendelian trait but a type 2 segmental manifestation of GNAS inactivation disorders: A hypothesis.
    Happle R
    Eur J Med Genet; 2016 May; 59(5):290-4. PubMed ID: 27058263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild progressive osseous heteroplasia overlap syndrome with PTH and TSH resistance appearing during adolescence and not early childhood.
    Ozaki K; Mituboshi A; Nagai M; Nishiyama A; Nishimura G; Morisada N; Iijima K
    Endocrine; 2021 Dec; 74(3):685-689. PubMed ID: 34254228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Paternal GNAS mutations: Which phenotypes? What genetic counseling?].
    Kottler ML
    Ann Endocrinol (Paris); 2015 May; 76(2):105-9. PubMed ID: 25952723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders.
    Lemos MC; Thakker RV
    Hum Mutat; 2015 Jan; 36(1):11-9. PubMed ID: 25219572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudohypoparathyroidism type Ib in 2015.
    Mantovani G; Elli FM
    Ann Endocrinol (Paris); 2015 May; 76(2):101-4. PubMed ID: 25910998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal osteoma cutis due to a mutation in GNAS.
    Levy-Shraga Y; Barel O; Javasky E; Barzilai A; Greenberger S
    Pediatr Dermatol; 2019 Sep; 36(5):732-734. PubMed ID: 31215057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Molecular Characteristics of GNAS Inactivation Disorders Observed in 18 Korean Patients.
    Han SR; Lee YA; Shin CH; Yang SW; Lim BC; Cho TJ; Ko JM
    Exp Clin Endocrinol Diabetes; 2021 Feb; 129(2):118-125. PubMed ID: 31546270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medulloblastoma in a child with osteoma cutis - a rare association due to loss of
    Suntharesan J; Lyulcheva-Bennett E; Hart R; Pizer B; Hayden J; Ramakrishnan R
    J Pediatr Endocrinol Metab; 2024 May; 37(5):467-471. PubMed ID: 38529810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GNAS mutations and heterotopic ossification.
    Bastepe M
    Bone; 2018 Apr; 109():80-85. PubMed ID: 28889026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients.
    Mantovani G; de Sanctis L; Barbieri AM; Elli FM; Bollati V; Vaira V; Labarile P; Bondioni S; Peverelli E; Lania AG; Beck-Peccoz P; Spada A
    J Clin Endocrinol Metab; 2010 Feb; 95(2):651-8. PubMed ID: 20061437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up Findings in a Turkish Girl with Pseudohypoparathyroidism Type Ia Caused by a Novel Heterozygous Mutation in the GNAS Gene.
    Şahin S; Hiort O; Thiele S; Evliyaoğlu O; Tüysüz B
    J Clin Res Pediatr Endocrinol; 2017 Mar; 9(1):74-79. PubMed ID: 27425121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paternal GNAS mutations lead to severe intrauterine growth retardation (IUGR) and provide evidence for a role of XLαs in fetal development.
    Richard N; Molin A; Coudray N; Rault-Guillaume P; Jüppner H; Kottler ML
    J Clin Endocrinol Metab; 2013 Sep; 98(9):E1549-56. PubMed ID: 23884777
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Yang W; Zuo Y; Zhang N; Wang K; Zhang R; Chen Z; He Q
    Front Endocrinol (Lausanne); 2023; 14():1255864. PubMed ID: 37920253
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.